DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Roufosse FE, Kahn JE, Gleich GJ. , et al.
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
J Allergy Clin Immunol 2013;
131 (02) 461-467.e1 , 5
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.